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Coping is defined as ’the cognitive and behavioral ef-
forts made by an individual to alter or manage the prob-
lems caused by stressful situations‘.1 The effectiveness 
of coping is associated with variables such as extent 
of social support,2,3 personality factors such as self-
esteem and control,4 and rate of occurrence of stress-
ful events.5 Individuals with active behavioural coping 
strategies are likely to have fewer mood disturbances, 
a better quality of life6 and a reduction in risk-taking 
behaviour,7 whereas individuals with inadequate and 
avoidant coping styles are likely to have higher levels 
of emotional stress and increased feelings of hopeless-
ness or negative expectations.3,8-11 
The dynamics of hope are multifaceted and comprise a 
complex combination of ’hope’, ‘despair’ and ’hopeless-
ness’.12 With hope, the individual fights against inability 
to cope and has the belief that life is worth living both 
in the present and the future. Despair is a downward 
process that results in being stuck in a situation, losing 
grip, sinking into a narrow existence, losing perspective 
of the future and questioning the possibility of hope.13 
Hopelessness includes helplessly giving up everything 
(including hope) and living in emptiness in the face of 
an assumed non-existent future. 
Hopelessness or negative expectation is among the psy-
chological variables that are predictive of suicide. The 
patient misconstrues his or her experience in a nega-
tive way and anticipates serious outcomes for his or her 
problems. This sense of hopelessness may lead the per-
son to believe that suicide is the only feasible strategy 
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Aim. The coping skills and styles individuals utilise to deal with the stress of HIV infection greatly influence the 
psychological impact of this illness and potential consequent feelings of hopelessness. The aim of this study was 
to describe levels of hopelessness in a group of stable, non-depressed HIV-positive patients receiving antiretro-
viral therapy, and factors associated with hopelessness.
Method. Thirty randomly selected non-depressed patients (according to Diagnostic and Statistical Manual of 
Mental Disorders, 4th edition (DSM-IV) criteria) were included in this study. Demographic and other data were 
obtained from all subjects, who also completed the Beck’s Hopelessness Scale (BHS). The 20 true-false items of 
the BHS (29) measured three major aspects of hopelessness, which was interpreted on the total scale score as 
follows: ≤3 minimal, and >3 significant. 
Results. The study population comprised 30 patients with a mean age of 37.9 years (standard error (SE) 1.18) 
(range 28 - 51 years). The mean BHS score was 4.03 (SE 0.55), with a range from 0 to 12. There were no sta-
tistically significant correlations between BHS scores of the study population and gender, marital status, em-
ployment status, level of education, years since the diagnosis of HIV, or number of children (p>0.05). Eighteen 
subjects (60%) scored 3 or less on the BHS, considered minimal levels of hopelessness. However, 12 (40%) scored 
more than 3, which is considered significant; of these 23% had scores of 7 or more. There was no statistically 
significant association between BHS scores and gender, employment status, level of education, number of chil-
dren or number of years since diagnosis (p>0.05). However, patients who were married or living with partners 
were statistically more likely to score higher on the hopelessness scale compared with those who were single 
(p<0.05).  
Conclusion. Hopelessness is a psychological distress reaction that is common but largely undetected in stable 
HIV-positive patients on antiretrovirals. Feelings of hopelessness may result in increase in risk-taking behaviour 
(e.g. unprotected sex, drug use, sharing needles) and attempted suicide. 
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for dealing with seemingly insoluble problems.14-17 Beck 
et al.,18 in a 10-year prospective follow-up study of 165 
patients hospitalised with suicidal ideation, confirmed 
that hopelessness was predictive of actual suicide. 
The prevalence of HIV and AIDS in South Africa has 
reached pandemic proportions. Living with HIV in a 
country where HIV is hugely stigmatised can be ex-
tremely stressful and causes mental suffering. The 
poorest sectors of society are most vulnerable and the 
consequences for them are most severe. Loss of income, 
additional care-related expenses and mounting medi-
cal fees push affected households deeper into poverty. 
The burden of coping often rests with women, who are 
faced with stepping up to a role as income-earners, 
mothers and caregivers. HIV has resulted in disintegra-
tion of family units and households. 
The effectiveness of the coping abilities and styles in-
dividuals utilise to deal with the stresses of HIV greatly 
influences the psychological impact of this illness. Fur-
thermore, the presence of co-morbid personality and 
adjustment disorders (which have an increased preva-
lence in the HIV-positive population)19 also impacts on 
coping abilities. Persons with these disorders are more 
likely to cope in a dysfunctional way.20 
There is evidence that hopelessness in individuals with 
HIV and AIDS may be associated with depression,21 
which may lead to decreased adherence to medication 
regimes, further suppression of immunity and acceler-
ated disease progression as well as risk of suicide. From 
a psychobiological perspective, active coping is asso-
ciated with higher total lymphocyte, CD4 and natural 
killer cell counts,22,23 while a passive24 or fatalistic– 
resigned coping style and hopelessness25 are associated 
with poor HIV treatment adherence and rapid progres-
sion of HIV disease,26 particularly if they are associ-
ated with depression and occurrence of severe stressful 
events.27,28 
To measure hopelessness, Beck et al.29 developed the 
20-item Beck’s Hopelessness Scale (BHS), applied ex-
ploratory factor analysis and argued that the scale 
measures three specific components (affective, moti-
vational and cognitive). The KR-20 coefficients (meas-
ures of the scale’s internal consistency) range from 
0.82 to 0.93. In general practice, the correlation be-
tween the BHS and ratings of hopelessness was 0.74 
and in suicide attempters it was 0.62. The hopelessness 
construct is a factor in many mental disorders and is 
highly correlated with measures of depression and sui-
cidal intent and ideation.30 
Much of the work on psychiatric morbidity in HIV has 
been done in the Western world. Despite the high prev-
alence of HIV in South Africa, very few studies have 
been published on the ability of individuals to cope 
with the illness. Furthermore, in South Africa HIV- 
infected patients may be at greater risk for psycho- 
pathology than patients in the developed world be-
cause of their potentially stressful living conditions. 
The aim of this report was to describe levels of hope-
lessness and associated factors in a group of stable, 
non-depressed HIV-positive patients receiving anti-
retroviral (ARV) therapy. 
METHODS
The study was part of a larger prospective, randomised 
and controlled study designed to compare response to 
treatment, effects on immune markers and adherence 
to ARVs in patients with depression compared with 
those without depression. The sampling was a conven-
ience sampling, as it included only patients attending 
the Perinatal HIV Research Unit clinic at Chris Hani 
Baragwanath Hospital, Johannesburg. Volunteers who 
were 18 years and older and medically stable and had 
been on antiretroviral therapy for more than 6 months 
were screened for possible inclusion in the study. 
Thirty randomly selected non-depressed patients (ac-
cording to Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition (DSM-IV) criteria) were included 
in the study. Depressive symptoms were determined 
using the Hamilton Depression Rating Scale (HAMD) 
(the higher cut-off score of 14 or more was regarded as 
indicative of a diagnosis of depression). Additional data 
(age, gender, marital status, employment status, level 
of education, number of children, and number of years 
since diagnosis of HIV) were obtained from all subjects, 
who also completed the BHS. The 20 true-false items 
of the BHS29 measured three major aspects of hope-
lessness, which was interpreted on the total scale score 
as follows: ≤3 minimal, and >3 significant. 
The study was approved by the Committee for Research 
on Human Subjects, University of the Witwatersrand. 
For statistical analyses, the subjects were divided into 
two groups, those with a BHS score of ≤3 and those 
with a score of >3. Descriptive statistics were comput-
ed as means and frequencies (count and percentages). 
Comparisons were made between the two groups with 
regard to gender, marital status, employment status, 
number of children, level of education and number of 
years since diagnosis by the use of contingency tables 
(chi-square test with Fischer’s exact test). Logistic re-
gression was computed to determine any significant 
correlations between BHS scores and exposure vari-
ables. All analysis was done using the Statistical Pack-
age for Social Sciences 10.0 for Windows (SPSS Inc., 
Chicago, Ill.). A value of p<0.05 was considered sig-
nificant.
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RESULTS
The study population comprised 30 patients, with a 
mean age of 37.9 years (standard error (SE) 1.18) (range 
28 - 51 years). All had acquired HIV infection through 
heterosexual contact and had disclosed their status to 
their partner or a significant member of their family. 
The majority of patients (63.3%) were on a nevirap-
ine-based first-line regimen. Adherence to medication 
was good, with most patients virally suppressed and 
with a mean CD4 count of 405.37 cells/µl (SE 48.26). 
Clinically all the patients were non-depressed, and the 
mean HAMD score was 2.1 (SE 1.63) with a range from 
0 to 5. 
The mean BHS score was 4.03 (SE 0.55), with a range 
from 0 to 12 (Fig. 1). 
Eighteen subjects (60%) scored 3 or less on the BHS, 
considered minimal levels of hopelessness. However, 12 
(40%) scored more than 3, which is considered signifi-
cant; of these 23% had scores of 7 or more. Compari-
sons between these two groups with respect to some 
variables are listed in Table I.
There were no statistically significant correlations be-
tween BHS scores of the study population and gender 
(r=-0.19, p=0.313), marital status (r=0.33, p=0.071), 
employment status (r =-0.26; p=0.162), level of edu-
cation (r=-0.22; p=0.240), years since the diagnosis of 
HIV (r=0.24; p=0.203), or number of children (r=0.11; 
p=0.567). However, there was a trend indicating that 
subjects who were female, unemployed, married and/
or had more children were more likely to experience 
higher levels of hopelessness. 
There was no statistically significant association be-
tween BHS scores and gender (p=0.184), employment 
status (p=0.769), level of education (p=0.933), number 
of children (p=0.933), or number of years since diag-
nosis (p=0.755). However, patients were who married 
or living with partners were statistically more likely to 
score higher on the hopelessness scale compared with 
those who were single (p=0.019). 
DISCUSSION
Although the sample was small, this study found that a 
significant proportion (40%) of a group of HIV-positive 
patients had mild to moderate levels of hopelessness as 
measured by the BHS, despite being medically stable, 
adherent to their antiretroviral medication and virally 
suppressed, and having high CD4 counts. Similar re-
sults of ’mild‘ feelings of hopelessness were reported by 
Remien et al.21 However, nearly all their patients main-
tained the conviction that good times lay ahead and 
that their lives were worthwhile. 
This finding is of relevance because there is published 
evidence that hopelessness may play a key role in the 
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 Study population  BHS score
Variables       (N=30) ≤3 (N=18) >3 (N=12)
Gender
   Male 6 (20%) 2 (6.7%) 4 (13.3%) Fisher’s exact  
   Female 24 (80%) 16 (53.3%) 8 (26.7%) p=0.184
Marital status
   Single/divorced/widowed 18 (60%) 14 (46.7%) 4 (13.3%) Fisher’s exact 
   Married/cohabiting 12 (40%) 4 (13.3%) 8 (26.7%) p=0.01912
Employment status
   Employed 9 (30%) 5 (16.7%) 4 (13.3%) Fisher’s exact 
   Unemployed 21 (70%) 13 (43.3%) 8 (26.7%) p=0.769
Level of education
   Grade 0 - 7 2 (6.7%) 1 (3.3%) 1 (3.3%) χ2=0.139; df 2; 
   Grade 8 - 12 25 (83.3%) 15 (50%) 10 (33.3%) p=0.933
   Tertiary 3 (10%) 2 (6.7%) 1 (3.3%)
No. of years since diagnosed
   0 - 5 11 (36.7%) 7 (23.3%) 4 (13.3%) Fisher’s exact 
   > 5  19 (63.3%) 11 (36.7%) 8 (26.7%) p=0.755
No. of children
   None 3 (10%) 2 (6.7%) 1 (6.7%) χ2=0.065; df 2; 
   1 10 (33.3%) 6 (20%)  4 (20%) p=0.967 
   >1 17 (56.7%) 10 (33.3%) 7 (33.3%)














Fig. 1. Histogram of Beck’s Hopelessness Scale scores. 
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prediction of suicidal behaviour.30 A high BHS score 
alerts the therapist to unstated or denied suicidal inten-
tions. Remien et al.21 reported that despite ’mild‘ feel-
ings of hopelessness and no current suicidal ideation, 
several of their patients considered suicide an option 
for the future should they become more impaired. In 
interpreting the results of the present study, hopeless-
ness may best be construed as a risk factor. However, 
unlike certain other predictors of suicide, such as age, 
sex, or race, hopelessness is a characteristic that can 
be modified. Given the relatively slow natural progres-
sion of HIV infection and the increased survival made 
possible by recent medical therapies, there should be 
a focus on interventions that promote the expression 
of negative feelings (i.e. anger) and the development 
of effective coping strategies that can significantly 
improve psychological status31 and possibly increase 
survival time.32 Failure to do this may mean that HIV-
positive subjects repress their feelings of anger and al-
leviate their discomfort by risk-taking behaviour such 
as unprotected sex, drug use and sharing needles.33 
Like the process of learning, which involves the for-
mation of new connections between nerve cells in the 
brain, psychotherapy works by changing the way the 
brain functions. Certain types of psychotherapy, partic-
ularly cognitive-behavioural therapy (CBT) and inter-
personal therapy (IPT), can help improve coping skills. 
The aim of IPT is to solve problems within a brief period 
rather than devise lifetime solutions, and its emphasis 
is on restoring the patient to an adequate level of func-
tioning rather than on personality change.34 A study by 
Rush et al.35 showed that depressed patients treated 
with cognitive therapy showed a more rapid reduction 
in hopelessness scores than a comparison group of de-
pressed patients treated with an antidepressant drug. 
Although this study did not find any significant corre-
lation between feelings of hopelessness and previously 
reported stressors such as unemployment, having more 
children to care for and lack of support, there were 
suggestions of a trend towards this. The small sample 
size and the very select sample in this study may have 
contributed to this finding. Contrary to Remien et al.’s21 
finding that long-term survivors of HIV and AIDS were 
more resilient and positive in terms of their mood and 
outlook, our patients appeared to become more hope-
less with time. It is possible  that we are not only fail-
ing to identify these feelings but do not provide any 
psychological support for persons expressing such feel-
ings at our ARV rollout clinics. 
A possible objection to the use of the BHS in prediction 
of suicide is that it yields a large proportion of false 
positives. The almost inevitable over-inclusiveness of 
valid predictors of a rare phenomenon such as suicide 
was first demonstrated by Meehl and Rosen36 and has 
since been widely discussed.37-39 However, it should be 
noted that the connotations of the terms ’false nega-
tive‘ and ’false positive‘ may not be completely appro-
priate. Generally these terms are applied when a spe-
cific test is able or unable to demonstrate the presence 
or absence of a known disease, such as diabetes or tu-
berculosis. The BHS attempts to identify the potential 
for fatal suicide attempts and not the behaviour itself. 
Many persons with high scores on this scale may con-
tinue to be at risk for suicide beyond the observation 
period, even though they have not yet made a fatal 
suicide attempt 
CONCLUSION
This small study suggests that hopelessness may be 
a common psychological distress reaction present in 
stable HIV-positive patients on ARVs that may go un-
detected. These feelings of hopelessness may result in 
an increase in risk-taking behaviour (e.g. unprotected 
sex, drug use, sharing needles) and attempted suicide. 
We recommend that the staff at ARV rollout clinics 
become aware of this possibility and use the BHS as 
a screening tool to identify such individuals and refer 
them for basic psychotherapy to improve coping skills 
and reduce feelings of hopelessness.   
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